Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 147 | 102 | 77 |
| Revenue growth | 44.2% | 33.4% | |
| Cost of goods sold | 37 | 30 | 23 |
| Gross profit | 110 | 73 | 54 |
| Gross margin | 74.8% | 71.1% | 69.9% |
| Sales and marketing | 92 | 60 | 37 |
| Research and development | 40 | 28 | 21 |
| General and administrative | 30 | 19 | 15 |
| EBIT | -51 | -34 | -20 |
| EBIT margin | -34.7% | -33.2% | -25.7% |
| Pre-tax income | -50 | -33 | -19 |
| Income taxes | 1 | 1 | 0 |
| Net income | -51 | -34 | -20 |
| Net margin | -34.4% | -33.3% | -25.5% |
| |
| Diluted EPS | ($1.50) | ($2.10) | ($1.31) |
| Shares outstanding (diluted) | 34 | 16 | 15 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|